tiprankstipranks
Eupraxia Pharmaceuticals (TSE:EPRX)
TSX:EPRX
Canadian Market
Holding TSE:EPRX?
Track your performance easily

Eupraxia Pharmaceuticals (EPRX) Financial Statements

21 Followers

Eupraxia Pharmaceuticals Financial Overview

Eupraxia Pharmaceuticals's market cap is currently ―. The company's EPS TTM is C$-1.24; its P/E ratio is ―; Eupraxia Pharmaceuticals is scheduled to report earnings on April 1, 2025, and the estimated EPS forecast is C$-0.20. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -5.99M$ -5.79M$ -5.83M$ -9.67M$ -6.11M
EBITDA$ -5.95M$ -5.75M$ -5.79M$ -9.66M$ -6.07M
Net Income Common Stockholders$ -5.94M$ -6.01M$ -6.04M$ -9.12M$ -6.31M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 8.66M$ 23.32M$ 35.91M$ 19.34M$ 33.21M
Total Assets$ 10.36M$ 24.98M$ 36.64M$ 20.27M$ 34.35M
Total Debt$ 93.05K$ 4.66M$ ―$ ―$ 198.76K
Net Debt$ -8.57M$ -18.66M$ ―$ ―$ -33.01M
Total Liabilities$ 2.39M$ 11.64M$ 18.53M$ 19.37M$ 19.29M
Stockholders Equity$ 9.52M$ 14.83M$ 19.54M$ 2.22M$ 17.04M
Cash Flow-
Free Cash Flow$ -10.23M$ -7.69M$ -6.13M$ -919.82K$ -7.96M
Operating Cash Flow$ -10.19M$ -7.71M$ -6.12M$ -878.64K$ -7.95M
Investing Cash Flow$ -42.27K$ 17.66K$ -6.79K$ -41.18K$ -12.75K
Financing Cash Flow$ -4.60M$ -4.50M$ 23.15M$ -7.29M$ 22.04M
Currency in USD

Eupraxia Pharmaceuticals Earnings and Revenue History

Eupraxia Pharmaceuticals Debt to Assets

Eupraxia Pharmaceuticals Cash Flow

Eupraxia Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis